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Antimicrobial resistance among clinically 
relevant bacterial isolates in Accra: 
a retrospective study
Jibril Mohammed1, Yaovi Mahuton Gildas Hounmanou2 and Line Elnif Thomsen2*
Abstract 
Objective: The aim of this study was to determine the antimicrobial resistance pattern of bacterial isolates from dif-
ferent specimens at various hospitals and private diagnostic service laboratories in Ghana.
Results: A retrospective data of culture and sensitivity test results from 2016 were extracted from the microbiology 
record book of six laboratories in Accra, Ghana. The data included type of clinical specimen, sex of patient, name of 
bacterial isolate and antibiotic resistance profile. A total of 16.6% (n = 10,237) resistant isolates were obtained, how-
ever, the proportions of resistant isolates varied significantly between laboratories. High resistance towards tetracy-
cline, ampicillin, cotrimoxazole and cephalosporins, but low towards amoxiclav and aminoglycosides, was observed. 
This study identified E. coli and Staphylococcus species as the major resistant bacteria from clinical specimen in Accra 
and the highest prevalence of the isolates was found in urine specimens in all six laboratories (69.1%, n = 204; 52.6%, 
n = 36; 52.3%, n = 350; 37.9%, n = 298; 53%, n = 219; 62.1%, n = 594) and in female patients (81.4, 50 and 69.5%). Regu-
lar surveillance and local susceptibility pattern analysis is extremely important in selecting the most appropriate and 
effective antibiotic for the treatment of bacterial infections.
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Introduction
One of modern medicine’s greatest achievements has 
been the production of antimicrobials against disease-
causing microbes, but after more than 70 years of wide-
spread use, these therapeutic agents have gradually lost 
their potency [1]. Antimicrobial resistance (AMR) is now 
a serious global health concern causing problems in the 
treatment and prevention of infections. Nevertheless, 
these microorganisms especially bacteria, causes some of 
the most common infections in different settings; in the 
community, in hospitals or transmitted through the food 
chain [2]. Antibiotics are among the most commonly 
prescribed drugs in hospitals and in developed countries 
about 30% of the hospitalized patients are treated with 
these drugs [3]. Antibiotic use in Africa is progressively 
on the rise and the availability of un-prescribed antibiot-
ics is part of the problem. A study combining data from 
various African countries revealed that approximately 
90.1% of cases of acute illness sought care outside the 
home and 36.2% took an antibiotic medication and over 
30% of the individuals acquired antibiotics without pre-
scription [4]. Several studies from various African coun-
tries have furthermore shown high levels of antibiotic 
resistant bacterial pathogens [5–9]. In spite of the ongo-
ing research on antimicrobial resistance, there are still no 
indications that the situation is abating. In order to for-
mulate an efficient AMR control plan, it is crucial to have 
a clear view on the current situation so as to determine 
when, how and where to initiate control measures. The 
present study assessed a 12  months trend of antimicro-
bial resistance in clinically relevant bacterial isolates in 
Accra, Ghana.
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Main text
Methods
Study design
This study was a retrospective analysis of miscellaneous 
clinical samples that were tested for bacterial presence 
and subsequent susceptibility testing dated from Janu-
ary to December 2016, from six locations comprising 
three hospitals and three private diagnostic service lab-
oratories. The study locations include Trust Specialist 
Hospital (TH), Holy Trinity Medical Center (HTMC), 
LA General Hospital (LAGH), Patholab Solutions 
(Ghana) Limited (PSGL), G2 Medical Laboratory and 
Mediplast Diagnostic Center (G2ML). All locations are 
situated in the city of Accra, Ghana and the data were 
sampled from January to May 2017.
Data extraction
The clinical information extracted from the six labora-
tories included type of sample analyzed, name of path-
ogens isolated and the names of antibiotics used for 
susceptibility testing and the susceptibility results as 
recorded in the laboratory report. All information were 
confirmed by each laboratory technician and recon-
firmed by the chief biomedical scientist.
Laboratory analysis, clinical samples and collection 
of bacterial isolates
Several types of clinical samples were cultured, includ-
ing urine, blood, sputum, urethral smear, pus and semi-
nal fluid, and swabs from various body sites (vagina, 
ear, throat, umbilical cord, eye and wound). All the lab-
oratories sampled for the current study employed simi-
lar standard microbiological culturing techniques.
Bacterial identification
All the laboratories performed similar microscopic 
identification as previously described [10]. For Gram-
positive cocci, tube coagulase and catalase were done 
for species differentiation. Further biochemical tests 
included lactose fermentation, indole, citrate utiliza-
tion, urease and Triple Sugar Iron reaction to ascertain 
the biochemical characteristics of the Gram-negative 
isolates. Two of the laboratories (Trust Hospital and 
Mediplast Diagnostic Center) also deployed the BBL 
Crystal Panel Viewer (Becton–Dickinson Maryland, 
USA) for further identification of isolates.
Antimicrobial susceptibility
Antimicrobial susceptibility test were performed by 
all 6 laboratories using the Kirby-Bauer disk diffusion 
method [11] and interpreted using the Clinical Labora-
tory Standard Institute guidelines [12]. Gram-positive 
and Gram-negative antibiotic disks were selected for 
Gram-positive and Gram-negative bacterial isolates, 
respectively. Each laboratory used disks manufactured 
by Abtek Biologicals, UK and Biomark Laboratories, 
India. The disks and their concentrations in micro-
grams included: ampicillin (AMP: 10), cotrimoxazole 
(COT: 25), amoxiclav (AMC: 20/10), nalidixic acid 
(NAL: 30), tetracycline (TET: 30), ceftriaxone (CTR: 
30), ceftazidime (CAZ: 30), nitrofurantoin (NIT: 300), 
gentamicin (GEN: 10), ciprofloxacin (CIP: 30), levoflox-
acin (LEV: 5), norfloxacin (NOR: 30), chlorampheni-
col (CHL: 10), cefuroxime (CRX: 30), amikacin (AMK: 
30), piperacillin (PIP: 100), nitrofurantoin (NTD: 200), 
cefotaxime (CTX: 30), penicillin (P: 1.5), flucloxacil-
lin (FLX: 1), erythromycin (ERY: 5), amoxicillin (AMX: 
30), ofloxacin (OF: 5), cloxacillin (CLX: 5), perfloxacin 
(PEF: 10), augmentin (AUG: 30), vancomycin (VAN: 
30), meropenem (MEM: 10), roxithromycin (RO: 15), 
sparfloxacin (SPX: 5), lincomycin (LM: 15), azithromy-
cin (AZM: 15), pipemidic acid (PPA: 20).
Data analysis
Collected data was entered into Microsoft Excel and 
loaded into statistical package for social sciences (SPSS, 
version 20) for analysis. Proportions of predominant iso-
lates and antibiotic resistance profiles were compared 
using Chi square test. The Pearson correlation test was 
used to assess associations among locations and isolates 
in relation to the resistance profile of the isolates at a crit-
ical probability P < 0.05.
Results
Records on resistant bacterial isolates and the antibi-
otic resistant profile cultured from January to December 
2016 in six microbiology laboratories were extracted. 
These laboratories include three hospitals namely Trust 
Hospital (TH), LA General Hospital (LAGH) and Holy 
Trinity Medical Center (HTMC) and three private diag-
nostic service laboratories, Mediplast Diagnostic Center 
(MDC), Patholab Solutions Ghana Limited (PSGL) and 
G2 Medical Laboratory (G2ML).
In the study period, a total of 10,237 samples were cul-
tured and 1701 (16.62%) resistant isolates were obtained. 
However, proportions of antibiotic resistant bacteria dif-
fered significantly from one laboratory to the other with 
PSGL samples generating the highest number of resist-
ant isolates (33.08%, P < 0.05), whereas isolates recovered 
at G2ML showed the lowest level of resistance (5.51%, 
P < 0.05) (Table 1).
Out of the six labs, nineteen different specimens 
were taken and statistical analysis revealed from all 
laboratories that urine samples are significantly more 
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contaminated with antibiotic resistant bacteria than all 
other sample types (P < 0.05, Additional file 1).
Samples were taken from female and male patients in 
all the six study areas but only three provided data on 
sex groups. A two by two comparison revealed for TH 
and LAGH that female gender is significantly associated 
with infection by antibiotic resistant bacteria compared 
to males (P < 0.05, Table 2). MDC had equal proportions 
(50%) of resistant bacteria from male and female patients 
(Table 2).
The predominant resistant bacterial species varied 
from one lab to the other, but E. coli and Staphylococcus 
were the main isolates from all the laboratories. From 
TH and G2ML, E. coli were the most recovered isolates 
(47.5%, n = 204 and 38.4%, n = 219, respectively). How-
ever, S. aureus prevailed in isolates recovered at MDC, 
PSGL and LAGH (22.2%, n = 36; 50.9%, n = 350 and 
29.5%, n = 298, respectively). Undistinguished resistant 
Staphylococcus species were the most common isolates 
from HTMC (44.8%, n = 594) (Table 3).
Records of the bacterial species and their resistance 
pattern can be found in Additional file 2. Here we sum-
marized the antibiotic resistance profile of the three 
predominant resistant isolates from each laboratory. At 
TH, E. coli, Enterococcus faecalis and Klebsiella spp were 
resistant to AMP, COT, AMC, NAL, TET, CRO, GEN, 
LEV, NOR, CXM, NTD and CTZ at varying proportions. 
At MDC, S. aureus, E.  coli and Enterobacter spp dis-
played resistance of varying degrees to AMP, COT, TET, 
CIP, NOR, CHL and CXM. Data from PSGL show that 
S. aureus, E.  coli and Pseudomonas spp demonstrated 
resistance to CEF, PIP, CHL, CTX, AMK, GEN, NAL, 
CFT, AUG, CIP, TET, NIT, VAN, CTR, MEM, COT, ERY 
AMP and CRX. From LAGH, the predominant isolates 
(S. aureus, E.  coli and Pseudomonas spp) were resistant 
to COT, CIP, GEN, AMP, MEM, TET, CRX, AMK, LEV, 
CTR and CTX. At G2ML S. aureus, E. coli and Citrobac-
ter spp showed resistance against GEN, CIP, AMP, AUG, 
COT, CRX, TET, CFT, PIP, NAL, CTX, CTR and CHL. 
The three predominant isolates (E. coli, Staphylococcus 
spp and Citrobacter freundi) from HTMC were resist-
ant to CPZ, CIP, CTR, PIP, CTX, TET, LEV, GEN, NX, 
AMK, NA, AMP, OF, CHL, CXM, COT, NIT, AMX, ERY, 
LM, RO and AZM with different proportions (Additional 
file 2).
Discussion
Antibiotic resistant bacterial infections have become 
a threat, in particular in developing countries, but to 
obtain an effective treatment plan, it is vital to have an 
overview of the current resistance level. In this study, 
data on culture and sensitivity results from six microbiol-
ogy laboratories were extracted. Within the entire period, 
each of the six laboratories reported varying numbers of 
antibiotic resistant bacteria strains ranging from 36 to 
594 resistant isolates. Statistical analysis revealed that 
samples from PSGL generated the highest proportions of 
resistant isolates (33.08%). There is therefore a possibility 
that patients living around or attending PSGL are likely 
to be more infected with antibiotic resistant bacteria, as it 
is situated in a densely populated area of residence, com-
pared to patients who attended the other laboratories. 
Isolates recovered at G2ML, located in an area which pri-
marily covers a business district, demonstrated the low-
est level of antibiotic resistance as compared to the rest 
(5.51%). Among the six labs, 19 different types of clinical 
specimen were processed, but the highest level of anti-
biotic resistant bacteria was found in the urine samples 
in all laboratories. The proportions of resistant isolates 
ranged from 37.9% and up to 69.1%. High level resist-
ance (66.7%) in urine has also been shown at the Korle-
Bu Teaching Hospital in Ghana [13]. In Sierra Leone 
85.7% of multidrug resistant isolates were identified in 
urine specimen [14]. Furthermore, the most prevailing 
resistant bacteria isolated from the various specimens in 
all the laboratories were E. coli and Staphylococcus. E. 
coli is the primary etiologic agent causing urinary tract 
infection, accounting for 90% of the cases [15], however, 
in this study we did not acquire data on disease state 
of patients. But our data showed that female patients 
from TH (81.37%) and LAGH (69.46%) had the high-
est level of resistant bacteria compared to males. That 
Table 1 Comparison of  antibiotic resistance 
between laboratories using Chi square test
Proportions followed by different letters in a column means differences in 
proportion of resistant isolates at α < 0.05%
Laboratories Number of isolates Resistant isolates (%)
TH 1515 204 (13.47d)
MDC 243 36 (14.81d)
PSGL 1058 350 (33.08a)
LAGH 1302 298 (22.89c)
G2ML 3978 219 (5.51e)
HTMC 2141 594 (27.74b)
Table 2 Repartition of resistant bacteria by sex of patients
TH Trust Hospital, MDC Mediplast Diagnostic Center, LAGH LA General Hospital
Laboratories Resistant isolates P-value
Females (%) Males (%)
TH 166 (81.37) 38 (18.63) 0.000001
MDC 18 (50) 18 (50) 0.8136
LAGH 207 (69.46) 91 (30.54) 0.000001
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significantly more resistant bacteria were found in female 
urine samples correlates with a higher susceptibility of 
infection in females than males, due to the physiologi-
cal and anatomical differences. Resistant Staphylococcus 
aureus recovered from various specimens were found in 
the range 10.3–50.9%. The undistinguished Staphylococ-
cus spp. (44.8%) from HTMC laboratory may be due to 
lack of special media or other requirements for accurate 
and definitive identification. High level antibiotic resist-
ant S. aureus has previous been shown in other studies 
from Ghana and Ethiopia [5, 16, 17]. Often, high levels 
of S. aureus are isolated from different sites of infection, 
probably due to the fact that this bacterium is part of the 
normal flora on skin and gut, but can infect breaches on 
the skin. Moreover, S. aureus is often found at the hospi-
tal settings, increasing the risk of infections. Due to the 
known risk of bacterial spread at hospitals, and lack of 
typing data, we cannot rule out that some of the resistant 
bacteria isolated from different specimen may in fact be 
the same clone.
Gram-negative bacteria accounted for 65.4% of the 
resistant bacteria, whereas Gram-positive accounted 
for 34.6%. Overall, S. aureus, E. coli, Citrobacter spp., 
Pseudomonas spp. and Enterobacter spp. from all the 
laboratories, showed high resistance against tetracy-
cline, ampicillin and cotrimoxazole. Similar report of 
high resistance to these antibiotics in Ghana has previ-
ously been reported [5, 18]. They are also regarded as 
the most widely used antibiotics in developing coun-
tries, as they are considered inexpensive and generally 
have broad-spectrum activity [19]. We also observed 
high resistance of Klebsiella spp. to ceftriaxone and 
cefuroxime, which has also been observed in a recent 
study from Rwanda [20]. But the resistance to amoxi-
clav, amikacin and chloramphenicol was low across 
most of the laboratories except at G2ML where resist-
ance towards amoxiclav (augmentin) was mostly high.
Table 3 Proportion of resistant bacterial species isolated from clinical samples from each laboratory
NR not reported, TH Trust Hospital, MDC Mediplast Diagnostic Center, PSGL Patholab Solutions (Ghana) Limited, LAGH LA General Hospital, G2ML G2 Medical 
Laboratory Service, HTMC Holy Trinity Medical Centre
Resistant isolates TH MDC PSGL LAGH G2ML HTMC
Number (%) Number (%) Number (%) Number (%) Number (%) Number (%)
Providencia spp. NR NR NR NR NR 53 (8.9)
M. morganii NR NR NR NR NR 3 (0.5)
Citrobacter spp. NR 1 (2.8) 1 (0.3) 17 (5.7) 23 (10.5) NR
S. aureus 21 (10.3) 8 (22.2) 178 (50.9) 88 (29.5) 28 (12.8) NR
Pseudomonas spp. 16 (7.8) 3 (8.3) 13 (3.7) 29 (9.7) 25 (11.4) 7 (1.2)
S. epidermidis 3 (1.5) 4 (11.1) 1 (0.3) 1 (0.3) 6 (2.7) NR
K. pneumoniae NR 1 (2.8) NR 1 (0.3) NR NR
P. aeruginosa NR 1 (2.8) 3 (0.9) 18 (6.0) 14 (6.4) 12 (2.0)
Enterobacter spp. 6 (2.9) 5 (13.9) NR 12 (4.0) 3 (1.4) 23 (3.9)
N. gonorrhoea 4 (2.0) 2 (5.6) NR NR 12 (5.5) NR
E. coli 97 (47.5) 7 (19.4) 120 (34.3) 6.8 (22.8) 84 (38.4) 86 (14.5)
Y. pestis NR 1 (2.8) NR NR NR NR
S. pyogenes NR NR NR NR NR 2 (0.3)
Proteus spp. 5 (2.5) 2 (5.6) 7 (2.0) 17 (5.7) NR 4 (0.7)
Klebsiella spp. 25 (12.3) 1 (2.8) 4 (1.1) 20 (6.7) 1 (0.5) 12 (2.0)
P. vulgaris NR NR 8 (2.3) NR 1 (0.5) NR
S. saprophyticus NR NR 7 (2.0) 6 (2.0) NR NR
E. faecalis 27 (13.2) NR 7 (2.0) NR NR NR
P. mirabilis NR NR 1 (0.3) 8 (2.7) 2 (0.9) NR
Enterococcus spp. NR NR NR 6 (2.0) 14 (6.4) 31 (5.2)
Acinetobacter spp. NR NR NR 1 (0.3) 1 (0.5) NR
Bacillus spp. NR NR NR 3 (1.0) NR 1 (0.2)
Streptococcus spp. NR NR NR 2 (0.7) 5 (2.3) NR
Salmonella spp. NR NR NR 1 (0.3) NR NR
Staphylococcus spp. NR NR NR NR NR 266 (44.8)
C. freundii NR NR NR NR NR 94 (15.8)
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Conclusion
Our analysis of the culture and sensitivity test results 
of the various species of bacteria isolated from differ-
ent clinical specimens at various microbiology labo-
ratories revealed that high levels of resistant bacteria 
were recovered from urine specimens. Furthermore, 
resistant E. coli and Staphylococcus species were the 
most prevalent isolates recovered from all the speci-
mens. Specimen from female patients presented the 
highest prevalence of resistant bacteria isolates as com-
pared to male patients. We observed high resistance to 
tetracycline, ampicillin, cotrimoxazole and the cepha-
losporins, but low resistance to amoxiclav and the ami-
noglycosides. The variations in resistance pattern of the 
bacterial isolates across the laboratories suggests that 
regular surveillance and local susceptibility pattern is 
extremely important in selecting the most appropriate 
and effective antibiotic for the treatment of bacterial 
infections.
Limitations of the study
Our study have some limitations due to lack of infor-
mation on the disease status of the patients, and it is 
possible that different specimens were collected from 
the same patient, resulting in isolation of the same bac-
terial species.
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